Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Health Economics and Outcomes Research Topic Center

Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024

Winston Wong, PharmD

Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Scott Swain, PhD.
Videos
Navigating the FDA’s Guidance on Real-World Evidence: Insights, Expectations, and Future Trends in Clinical Trials
02/02/2024

Featuring Scott Swain, PhD, MPH

Featuring Scott Swain, PhD, MPH ...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director...
02/02/2024
Journal of Clinical Pathways
News
Disparities in Palliative Care Access Highlighted in Nationwide Study of Deceased Lymphoma Patients
12/04/2023

Edited by Brandon Twyford

Edited by Brandon Twyford
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that...
12/04/2023
Journal of Clinical Pathways
The role of cost in pathways panel discussion at CPC & CBEx 2023.
News
The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs
10/12/2023

Brandon Twyford

Brandon Twyford
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC...
10/12/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023

Emry Lloyd

Emry Lloyd
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023

David Blaisdell; Blog Editor: Tom Valuck, MD, JD

David Blaisdell; Blog Editor: Tom Val...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
Clinical Pathways in Practice at Roswell Park Cancer Center
09/05/2023

Featuring Stephen Edge, MD

Featuring Stephen Edge, MD
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
Conference Coverage
Hospital Costs and Health Care Resource Utilization for Chimeric Antigen T-Cell Therapy and Stem Cell Transplant in Patients with Large B-Cell Lymphoma in the United States
12/12/2022

Katie Herman

Katie Herman
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting...
12/12/2022
Journal of Clinical Pathways
Conference Coverage
Cost-Related Medication Nonadherence Among Cancer Survivors in Rural and Urban Settings
10/04/2021

Marta Rybczynski

Marta Rybczynski
According to a study presented at the 2021 ASCO Quality Care Symposium, cost-related prescription nonadherence is associated with higher health care cost responsibility in cancer survivors, especially for those living in rural compared to...
According to a study presented at the 2021 ASCO Quality Care Symposium, cost-related prescription nonadherence is associated with higher health care cost responsibility in cancer survivors, especially for those living in rural compared to...
According to a study presented...
10/04/2021
Journal of Clinical Pathways
The Importance of Qualitative Research in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment
Pharma Insights
The Importance of Qualitative Research in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment
05/19/2021
Suepattra G May, MPH, PhD
Meaghan Roach, MPH
Richard Murphy, BA
Suepattra May, MPH, PhD, and colleagues believe upfront qualitative research conducted directly with stakeholders is needed to generate both a baseline understanding of the patient perspective and to identify the appropriate themes and...
Suepattra May, MPH, PhD, and colleagues believe upfront qualitative research conducted directly with stakeholders is needed to generate both a baseline understanding of the patient perspective and to identify the appropriate themes and...
Suepattra May, MPH, PhD, and...
05/19/2021
Journal of Clinical Pathways
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
02/22/2021
Jason Shafrin, PhD
Marlon Graf, PhD
Rifat Tuly, MPH
Christoph Glaetzer, Dipl Kfm
Stacey Hickson, PhD
T Joseph Mattingly II, PhD, PharmD, MBA
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
...
02/22/2021
Journal of Clinical Pathways

Expert Insights

Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024

Winston Wong, PharmD

Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Scott Swain, PhD.
Videos
Navigating the FDA’s Guidance on Real-World Evidence: Insights, Expectations, and Future Trends in Clinical Trials
02/02/2024

Featuring Scott Swain, PhD, MPH

Featuring Scott Swain, PhD, MPH ...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director...
02/02/2024
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023

David Blaisdell; Blog Editor: Tom Valuck, MD, JD

David Blaisdell; Blog Editor: Tom Val...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
Clinical Pathways in Practice at Roswell Park Cancer Center
09/05/2023

Featuring Stephen Edge, MD

Featuring Stephen Edge, MD
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
The Need for Continuous Cost-Effectiveness Analysis
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Interview
Clinical Pathways in Community Oncology: Assessing the Work of the American Society of Clinical Oncology Task Force on Clinical Pathways
02/13/2017
JCP Editors
Providers and practices across medical specialties have eagerly adopted clinical pathways in efforts to standardize care and achieve uniform outcomes. However, few disciplines have been as receptive to the concept of...
Providers and practices across medical specialties have eagerly adopted clinical pathways in efforts to standardize care and achieve uniform outcomes. However, few disciplines have been as receptive to the concept of...
...
02/13/2017
Journal of Clinical Pathways
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
Blog
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
08/07/2024
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together...
08/07/2024
Journal of Clinical Pathways
Farrukh Awan, MD
Videos
Chronic Lymphocytic Leukemia Treatment Updates
07/31/2024
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some...
07/31/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Why People Should Care About How Health Care Works (Part 1)
07/29/2024
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part...
07/29/2024
Cancer Care Business Exchange
Ivy Altomare, MD
Videos
Characteristics of Clinical Trials in Community Oncology Practices Across the US
07/23/2024
Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.
Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.
Ivy Altomare, MD, provides an...
07/23/2024
Journal of Clinical Pathways
Laura Bray
Videos
Advocacy to Reduce the Impact of Drug Shortages on Cancer Care
07/23/2024
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her...
07/23/2024
Journal of Clinical Pathways
Sandip Patel, MD
Videos
Recent Advancements in the Non–Small Cell Lung Cancer Treatment Landscape
07/22/2024
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the...
07/22/2024
Journal of Clinical Pathways
Steve Kalloger, MSc
Videos
Trends in Therapeutic Utilization Among Patients With CLL: Results From the Lymphoma Coalition’s 2022 Global Patient Survey Presented at ASCO 2024
07/18/2024
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses...
07/18/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Show Me the Medical Evidence
07/15/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health...
07/15/2024
Cancer Care Business Exchange
Gunjan Sharma
Interview
Leveraging Data to Enhance Patient Care: Addressing Social Determinants of Health in Oncology Care
07/10/2024
US Oncology Network analyst Gunjan Sharma shares insights on the impact of health-related social needs, Beer’s criteria medication prescribing patterns, and how research can inform the development of support services for patients with cancer.
US Oncology Network analyst Gunjan Sharma shares insights on the impact of health-related social needs, Beer’s criteria medication prescribing patterns, and how research can inform the development of support services for patients with cancer.
US Oncology Network analyst...
07/10/2024
Journal of Clinical Pathways
Stephen Colvill, MBA
Conference Coverage
How Collaboration Among Health Care Stakeholders Can Help Mitigate Drug Shortages
07/08/2024
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses...
07/08/2024
Journal of Clinical Pathways

Newsfeed

News
Disparities in Palliative Care Access Highlighted in Nationwide Study of Deceased Lymphoma Patients
12/04/2023

Edited by Brandon Twyford

Edited by Brandon Twyford
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that...
12/04/2023
Journal of Clinical Pathways
The role of cost in pathways panel discussion at CPC & CBEx 2023.
News
The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs
10/12/2023

Brandon Twyford

Brandon Twyford
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC...
10/12/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023

Emry Lloyd

Emry Lloyd
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways
Conference Coverage
Hospital Costs and Health Care Resource Utilization for Chimeric Antigen T-Cell Therapy and Stem Cell Transplant in Patients with Large B-Cell Lymphoma in the United States
12/12/2022

Katie Herman

Katie Herman
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting...
12/12/2022
Journal of Clinical Pathways
News
ICER Use of Real-World Evidence in Scoping Process and Clinical Evidence Assessments
01/13/2021
01/13/2021
Journal of Clinical Pathways
News
Do ICER Methodologies Align With Established Research Standards?
01/13/2021
01/13/2021
Journal of Clinical Pathways
News
AACI Clinical Research Innovation Committee Survey Evaluates Complexity of Clinical Trials Offices
01/05/2021
01/05/2021
Journal of Clinical Pathways
News
Care Model Beneficial for Estimating Impact of MM Treatment on Payers
09/22/2020
09/22/2020
Journal of Clinical Pathways
News
Analysis Explores Economic Burden of Ovarian Cancer in Commercially Insured Population
08/18/2020
Working-age patients with metastatic ovarian cancer experience significantly higher costs compared to those without cancer, according to findings from an analysis published in the Journal of Managed Care &...
Working-age patients with metastatic ovarian cancer experience significantly higher costs compared to those without cancer, according to findings from an analysis published in the Journal of Managed Care &...
...
08/18/2020
Journal of Clinical Pathways
News
Economic, Clinical Burden of AML Treatment Episodes in Commercially Insured Patients
07/02/2020
A new retrospective analysis highlights a “substantial economic burden” associated with key acute myeloid leukemia (AML) treatment episodes in commercially insured patients. Results of the analysis were published in...
A new retrospective analysis highlights a “substantial economic burden” associated with key acute myeloid leukemia (AML) treatment episodes in commercially insured patients. Results of the analysis were published in...
A new...
07/02/2020
Journal of Clinical Pathways
News
Examining Treatment Delay Trends in Patients With Lung Cancer
07/24/2024
A study in Missouri uncovers a disturbing trend of increasing delays in lung cancer treatment initiation, surpassing national guidelines and prompting a call for further investigation into potential causes.
A study in Missouri uncovers a disturbing trend of increasing delays in lung cancer treatment initiation, surpassing national guidelines and prompting a call for further investigation into potential causes.
A study in Missouri uncovers a...
07/24/2024
Journal of Clinical Pathways
News
First-Line Amivantamab Plus Lazertinib Superior to Osimertinib Among Patients With Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
07/18/2024
Results from the phase 3 MARIPOSA study found that first-line amivantamab plus lazertinib demonstrated superior efficacy compared to osimertinib among patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer.
Results from the phase 3 MARIPOSA study found that first-line amivantamab plus lazertinib demonstrated superior efficacy compared to osimertinib among patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer.
Results from the phase 3...
07/18/2024
Oncology
News
Perioperative Nivolumab Prolonged Event-Free Survival Compared to Perioperative Chemotherapy Among Patients With Resectable Non-Small Cell Lung Cancer
07/15/2024
Results from the phase 3 CheckMate 77T trial demonstrated that perioperative nivolumab prolonged event-free survival compared to perioperative chemotherapy among patients with resectable non-small cell lung cancer.
Results from the phase 3 CheckMate 77T trial demonstrated that perioperative nivolumab prolonged event-free survival compared to perioperative chemotherapy among patients with resectable non-small cell lung cancer.
Results from the phase 3...
07/15/2024
Oncology
News
Improving Care for Patients With Cancer Through Early Goal of Care Discussions
07/03/2024
Standardizing electronic documentation of physician-led goals of care discussions in patients with cancer can lead to improved care integration across health care settings, ensuring comprehensive and individualized quality care for patients...
Standardizing electronic documentation of physician-led goals of care discussions in patients with cancer can lead to improved care integration across health care settings, ensuring comprehensive and individualized quality care for patients...
Standardizing electronic...
07/03/2024
Journal of Clinical Pathways
Conference Coverage
The Association Between High Deductible Health Plans and Cancer Survival
07/02/2024
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented...
07/02/2024
Journal of Clinical Pathways
News
Impact of Care Delays on Health Care Resource Utilization in Patients With Early-Stage Lung Cancer
06/26/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
06/26/2024
Journal of Clinical Pathways
News
GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine
06/10/2024
Grace Taylor, MS, MA
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare...
06/10/2024
Journal of Clinical Pathways
News
Phase 3 KEYNOTE-522 Trial Meets Overall Survival Endpoints in Patients With TNBC
05/30/2024
Grace Taylor, MS, MA
Merck announced that their phase 3 KEYNOTE-522 trial evaluating pembrolizumab (Keytruda) met its overall survival endpoint for treating patients with high-risk early-state triple-negative breast cancer (TNBC).
Merck announced that their phase 3 KEYNOTE-522 trial evaluating pembrolizumab (Keytruda) met its overall survival endpoint for treating patients with high-risk early-state triple-negative breast cancer (TNBC).
Merck announced that their phase...
05/30/2024
Journal of Clinical Pathways
News
Ajax Therapeutics Receives FDA Clearance to Initiate Phase 1 Clinical Study of AJ1-11095 for Myelofibrosis
05/23/2024
Grace Taylor, MS, MA
Ajax Therapeutics received clearance from the US Food and Drug Administration (FDA) to begin a phase 1 clinical study of AJ1-11095, a first-in-class type 2 JAK2 inhibitor, for treating myelofibrosis.
Ajax Therapeutics received clearance from the US Food and Drug Administration (FDA) to begin a phase 1 clinical study of AJ1-11095, a first-in-class type 2 JAK2 inhibitor, for treating myelofibrosis.
Ajax Therapeutics received...
05/23/2024
Journal of Clinical Pathways
News
Patients With Breast Cancer Experience High Economic Burden and Lower HRQoL: Literature Review
05/15/2024
Grace Taylor, MS, MA
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review...
05/15/2024
Journal of Clinical Pathways

Research in Review

Research in Review
Costs and Complications Associated With Repeated Breast-Conserving Surgery for Breast Cancer
08/09/2017
JCP Editors
More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications, according...
More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications, according...
More...
08/09/2017
Journal of Clinical Pathways
Research in Review
Comparing Prognostic Values of MRI or PET-CT at Multiple Myeloma Diagnosis
07/12/2017
JCP Editors
Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...
Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...
...
07/12/2017
Journal of Clinical Pathways
Research in Review
Intensified Regimens More Effective Than Standard Therapy in DLBCL
06/28/2017
JCP Editors
Intensified regimens improve event-free survival (EFS) and overall survival (OS) in patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) compared with standard therapy, according to research presented...
Intensified regimens improve event-free survival (EFS) and overall survival (OS) in patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) compared with standard therapy, according to research presented...
...
06/28/2017
Journal of Clinical Pathways
Research in Review
Cost-Effective Substitute for Breast Cancer MRI Identified
06/26/2017
JCP Editors
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A...
06/26/2017
Journal of Clinical Pathways
Research in Review
DLBCL Survival Outcomes Improved With Combination Therapy
06/22/2017
JCP Editors
Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...
Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...
...
06/22/2017
Journal of Clinical Pathways
Research in Review
Reducing Cancer Drug Waste May Lead to Significant Cost Savings
06/13/2017
JCP Editors
Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...
Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...
...
06/13/2017
Journal of Clinical Pathways
Research in Review
Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing
05/31/2017
JCP Editors
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women...
05/31/2017
Journal of Clinical Pathways
Research in Review
Cost-Effectiveness of Early-Stage Breast Cancer Treatment Options Vary Significantly
04/21/2017
JCP Editors
Certain therapy options for early-stage breast cancer have fewer associated complications and are much less expensive than others, according to a study published in the Journal of the National Cancer Institute...
Certain therapy options for early-stage breast cancer have fewer associated complications and are much less expensive than others, according to a study published in the Journal of the National Cancer Institute...
...
04/21/2017
Journal of Clinical Pathways
Research in Review
Cost-Related Medication Non-Adherence More Likely Among Certain Patients
12/29/2016
JCP Editors
A new study sheds light on factors that make it more likely patients with cancer will not adhere to their treatment because of cost reasons. ----- Related Content Cognitive Factors Linked to Treatment Adherence in...
A new study sheds light on factors that make it more likely patients with cancer will not adhere to their treatment because of cost reasons. ----- Related Content Cognitive Factors Linked to Treatment Adherence in...
A new...
12/29/2016
Journal of Clinical Pathways
Research in Review
Study Identifies Steep Price Hikes for Older Cancer Drugs
10/17/2016
JCP Editors
The rising cost of cancer drugs continues to draw criticism from leading academic researchers, and threatens health care budgets. In a new study, researchers found that the price of older drugs increased more in a...
The rising cost of cancer drugs continues to draw criticism from leading academic researchers, and threatens health care budgets. In a new study, researchers found that the price of older drugs increased more in a...
The...
10/17/2016
Journal of Clinical Pathways
Research in Review
Research in Review Focus on Cancer
06/16/2022
JCP Editors
J Clin Pathways. 2022;8(5):12. Immune Checkpoint Inhibitors May Have Been Used Inappropriately in Half of Study Patients With Advanced Cancer Who Were Near the End of Life Immune checkpoint inhibitors (ICIs) have revolutionized the...
J Clin Pathways. 2022;8(5):12. Immune Checkpoint Inhibitors May Have Been Used Inappropriately in Half of Study Patients With Advanced Cancer Who Were Near the End of Life Immune checkpoint inhibitors (ICIs) have revolutionized the...
J Clin Pathways....
06/16/2022
Journal of Clinical Pathways
Research in Review
Research in Review Focus on Ovarian Cancer
05/20/2022
JCP Editors
J Clin Pathways. 2022;8(4):8-11. Progression-Free Survival Associated With Olaparib With or Without Cediranibvs Platinum-Based Chemotherapy in Women With High-Grade Ovarian Cancer Study findings suggest that neither olaparib monotherapy...
J Clin Pathways. 2022;8(4):8-11. Progression-Free Survival Associated With Olaparib With or Without Cediranibvs Platinum-Based Chemotherapy in Women With High-Grade Ovarian Cancer Study findings suggest that neither olaparib monotherapy...
J Clin Pathways....
05/20/2022
Journal of Clinical Pathways
Research in Review
Highlights from the Community Oncology Alliance (COA) 2022 Community Oncology Conference
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways
Research in Review
Research in Review Focus on Lung Cancer
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways
Research in Review
Reviewing the Latest Research on Multiple Myeloma
03/16/2022
JCP Editors
03/16/2022
Journal of Clinical Pathways
Research in Review
Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine
03/16/2022
JCP Editors
03/16/2022
Journal of Clinical Pathways
Research in Review
Highlights from the 63rd American Society of Hematology (ASH) Annual Meeting
02/15/2022
JCP Editors
02/15/2022
Journal of Clinical Pathways
Research in Review
Research in Review
06/21/2021
JCP Editors
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways....
06/21/2021
Journal of Clinical Pathways
Research in Review
Research in Review
05/20/2021
JCP Editors
Treatment Patterns After EGFR-TKI and Platinum-Based Chemotherapy Discontinuation in Metastatic NSCLC Study results show that immunotherapy is the most common next line of therapy after discontinuation of an...
Treatment Patterns After EGFR-TKI and Platinum-Based Chemotherapy Discontinuation in Metastatic NSCLC Study results show that immunotherapy is the most common next line of therapy after discontinuation of an...
...
05/20/2021
Journal of Clinical Pathways
Research in Review
Research in Review
04/22/2021
JCP Editors
Digital Care Delivery Models and Staffing Concerns Amidst the COVID-19 Pandemic A panel at the virtual ACCC 47th Annual Meeting & Cancer Center Business Summit shared real-world experiences on the impact of the...
Digital Care Delivery Models and Staffing Concerns Amidst the COVID-19 Pandemic A panel at the virtual ACCC 47th Annual Meeting & Cancer Center Business Summit shared real-world experiences on the impact of the...
...
04/22/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Recent Stories

Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024

Winston Wong, PharmD

Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Scott Swain, PhD.
Videos
Navigating the FDA’s Guidance on Real-World Evidence: Insights, Expectations, and Future Trends in Clinical Trials
02/02/2024

Featuring Scott Swain, PhD, MPH

Featuring Scott Swain, PhD, MPH ...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director...
02/02/2024
Journal of Clinical Pathways
News
Disparities in Palliative Care Access Highlighted in Nationwide Study of Deceased Lymphoma Patients
12/04/2023

Edited by Brandon Twyford

Edited by Brandon Twyford
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that...
12/04/2023
Journal of Clinical Pathways
The role of cost in pathways panel discussion at CPC & CBEx 2023.
News
The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs
10/12/2023

Brandon Twyford

Brandon Twyford
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC...
10/12/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023

Emry Lloyd

Emry Lloyd
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement